Max Healthcare Institute Ltd
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
Strengths
- +Company is almost debt free.
- +Company has delivered good profit growth of 203% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 18.7%
Weaknesses
- −Stock is trading at 11.9 times its book value
- −Company has a low return on equity of 9.70% over last 3 years.
- −Earnings include an other income of Rs.293 Cr.
- −Debtor days have increased from 33.1 to 40.5 days.
Shareholding Pattern
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.74% | 23.72%▼0.0 | 23.71%▼0.0 |
| FIIs | 56.99% | 57.29%▲0.3 | 56.93%▼0.4 | 54.74%▼2.2 | 54.76%▲0.0 | 51.8%▼3.0 | 50.55%▼1.3 | 45.39%▼5.2 |
| DIIs | 15.36% | 15.14%▼0.2 | 15.55%▲0.4 | 17.59%▲2.0 | 17.41%▼0.2 | 20.03%▲2.6 | 21.2%▲1.2 | 26.32%▲5.1 |
| Public | 3.91% | 3.84%▼0.1 | 3.77%▼0.1 | 3.94%▲0.2 | 4.09%▲0.1 | 4.43%▲0.3 | 4.52%▲0.1 | 4.58%▲0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 597 | 591 | 610 | 621 | 686 | 697 | 659 | 694 | 737 | 711 |
| Expenses | 394 | 391 | 407 | 423 | 461 | 461 | 484 | 506 | 523 | 507 |
| Operating Profit | 203 | 200 | 203 | 198 | 225 | 236 | 175 | 188 | 214 | 204 |
| OPM % | 34% | 34% | 33% | 32% | 33% | 34% | 27% | 27% | 29% | 29% |
| Net Profit | 161 | 158 | 242 | 154 | 231 | 138 | 177 | 166 | 160 | 187 |
| EPS ₹ | 1.66 | 1.63 | 2.49 | 1.59 | 2.38 | 1.42 | 1.82 | 1.71 | 1.65 | 1.92 |
AI Insights
TTM revenue at ₹2,800Cr, up 5.1% YoY. OPM at 28%.
Borrowings at ₹705Cr. Debt-to-equity ratio: 0.09x. Healthy balance sheet.
CWIP at ₹345Cr (7% of fixed assets). Moderate ongoing capital expenditure.
DIIs: 26.32% (+14.42pp change). FIIs: 45.39% (-14.50pp change). Promoters hold 23.71%.
ROCE improving from 0% (Mar 2013) to 13% (Mar 2025). Working capital days: -24.
PE 147x with 12.5% ROCE. Price is 1114% above book value of ₹87.3. Dividend yield: 0.14%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2d - Schedule of Earnings call for investors and Analysts
- Board Meeting Intimation for Board Meeting Intimation For Financial Results And Recommendation Of Final Dividend 2d - Board to meet on May 21, 2026 to approve FY26 results and consider final dividend.
- Minutes Of Postal Ballot 14 May
- Re-Classification Of Radiant Life Care Hospital Foundation From Promoter Group To Public Category 13 May - RLCHF seeks reclassification from promoter group to public after stake sale; board to consider.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 12 May
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse